Showing results (241-250 of 530) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|September 22, 2022
RNA-targeted therapeutics in cardiovascular disease: the time is nowKonstantin A Krychtiuk, Daniel J Rader, Christopher B Granger
European Heart Journal. Cardiovascular Pharmacotherapy|October 29, 2022
Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibitionSeth S Martin, Marc Ditmarsch, Mark Simmons, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 18, 2025
Prognostic Benefit of GLP-1 RA Addition to SGLT2i in Patients with ASCVD and Heart Failure: A Cohort StudySih-Yao Chen, Jheng-Yan Wu, Kuang-Ming Liao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 4, 2025
Valve thrombosis and antithrombotic therapy after bioprosthetic mitral valve replacement: a systematic review and meta-analysisMark J Zorman, Jonathan Vibhishanan, Katerina Dangas, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 29, 2024
Lipid-lowering therapies for aortic stenosis: a drug-target Mendelian randomization studyJonathan L Ciofani, Daniel Han, Karan Rao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 25, 2025
Trial-level Surrogacy of non-High-Density and Low-Density Lipoprotein Cholesterol Reduction on the Clinical Efficacy of StatinsLéa Liaigre, Alicia Guigui, Marc Manceau, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 30, 2025
Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drugStefano Fumagalli, Melania Dovizio, Stefania Mazzoni, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 31, 2019
Adherence to statin therapy favours survival of patients with symptomatic peripheral artery diseaseJörn F Dopheide, Jonas Veit, Hana Ramadani, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 31, 2019
Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillationJawad H Butt, Ole De Backer, Jonas B Olesen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 11, 2021
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery diseaseFrancesco Franchi, Fabiana Rollini, Latonya Been, et al.
Pageof 53